GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (NAS:APTO) » Definitions » E10

Aptose Biosciences (Aptose Biosciences) E10 : $-13.78 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Aptose Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Aptose Biosciences's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.440. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-13.78 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 8.50% per year. During the past 5 years, the average E10 Growth Rate was 7.80% per year. During the past 10 years, the average E10 Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Aptose Biosciences was 40.40% per year. The lowest was 3.50% per year. And the median was 18.60% per year.

As of today (2024-05-05), Aptose Biosciences's current stock price is $1.20. Aptose Biosciences's E10 for the quarter that ended in Dec. 2023 was $-13.78. Aptose Biosciences's Shiller PE Ratio of today is .


Aptose Biosciences E10 Historical Data

The historical data trend for Aptose Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences E10 Chart

Aptose Biosciences Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.41 -18.60 -16.84 -14.41 -13.78

Aptose Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.41 -14.01 -14.08 -13.74 -13.78

Competitive Comparison of Aptose Biosciences's E10

For the Biotechnology subindustry, Aptose Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptose Biosciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's Shiller PE Ratio falls into.



Aptose Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aptose Biosciences's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.44/125.4675*125.4675
=-1.440

Current CPI (Dec. 2023) = 125.4675.

Aptose Biosciences Quarterly Data

per share eps CPI Adj_EPS
201311 -10.173 97.182 -13.134
201402 -6.471 98.051 -8.280
201405 -6.774 99.394 -8.551
201409 0.000 99.394 0.000
201503 -3.549 99.789 -4.462
201506 -3.384 100.500 -4.225
201509 -3.017 100.421 -3.769
201512 -4.108 99.947 -5.157
201603 -4.853 101.054 -6.025
201606 -5.333 102.002 -6.560
201609 -3.558 101.765 -4.387
201612 -2.902 101.449 -3.589
201703 -2.850 102.634 -3.484
201706 -1.650 103.029 -2.009
201709 -1.650 103.345 -2.003
201712 -1.800 103.345 -2.185
201803 -3.450 105.004 -4.122
201806 -4.500 105.557 -5.349
201809 -2.400 105.636 -2.851
201812 -2.250 105.399 -2.678
201903 -2.100 106.979 -2.463
201906 -1.950 107.690 -2.272
201909 -1.800 107.611 -2.099
201912 -1.950 107.769 -2.270
202003 -2.250 107.927 -2.616
202006 -3.150 108.401 -3.646
202009 -2.250 108.164 -2.610
202012 -2.400 108.559 -2.774
202103 -2.700 110.298 -3.071
202106 -2.250 111.720 -2.527
202109 -1.950 112.905 -2.167
202112 -4.050 113.774 -4.466
202203 -1.800 117.646 -1.920
202206 -1.720 120.806 -1.786
202209 -1.590 120.648 -1.654
202212 -1.630 120.964 -1.691
202303 -2.250 122.702 -2.301
202306 -2.270 124.203 -2.293
202309 -1.760 125.230 -1.763
202312 -1.440 125.468 -1.440

Add all the adjusted EPS together and divide 10 will get our e10.


Aptose Biosciences  (NAS:APTO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Aptose Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptose Biosciences (Aptose Biosciences) Business Description

Traded in Other Exchanges
Address
251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Executives
Bernd R. Seizinger director 535 BOYLSTON STREET, BOSTON MA 02116
William G. Rice director, officer: Chair, President & CEO C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Fletcher Payne officer: SR VP & Chief Fin. Officer 260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO CA 94080
Philippe Ledru officer: Chief Commercial Officer C/O APTOSE BIOSCIENCES INC., 2511 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Denis R Burger director CYTODYN INC., 1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660
Erich Platzer director
Rafael Bejar officer: Chief Medical Officer C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Wilson Donald R. Jr. 10 percent owner 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Drw Holdings, Llc 10 percent owner 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Drw Commodities, Llc 10 percent owner 540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Warren Whitehead director C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Gregory K. Chow officer: Senior VP & CFO C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Jotin Marango officer: Senior VP, Chief Bus. Officer C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Caroline M Loewy director 300 ELLIOTT AVE WEST, SUITE 500, SEATTLE WA 98119-4114
Mark D. Vincent director C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3